Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease - Ownership and Business Overview

Life ScienceCompany

Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease Ownership

Who owns Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease?

Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease is owned by Humanigen. It was acquired on December 3, 2015.

Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease Business Overview

Where is Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease headquartered?

Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease is headquartered in United States.

What sector is Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease in?

Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease is a life science company.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease


United States,

Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease provides antitrypanosomal treatment for all cases of acute and congenital Chagas disease, reactivated infection, and chronic T. cruzi infection in individuals 18 years or younger.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 206,393
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease

Life Science Companies , United States Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal